Home > Healthcare & Medical Devices > Veterinary Infectious Disease Diagnostics Market
The veterinary infectious disease diagnostics market was expected to value over USD 1.5 billion in 2022. It is anticipated to see substantial gains of around 8-10% by 2032. Pet ownership can have health, emotional, and social benefits; however, pets can act as a source of zoonotic pathogens, necessitating the maintenance of pet health and cleanliness to reduce the risk of zoonotic disease transfer. Veterinary infectious disease diagnostics are products that are used to identify & determine the presence of infections, such as viruses, bacteria, and parasites, in animals.
The increasing pet ownership is significantly driving the demand for pet care & related products. According to the FEDIAF European Pet Food, based on the statistics & figures in 2022, around 90 million residents own a pet including 110 million to 90 million cats, 50 million birds, 30 million small animals, and 15 million aquariums, and 10 million terrariums. The major factors influencing market revenue growth include the rising incidences of zoonotic diseases, the increasing number of veterinary practitioners, technological advancements in Point of Care (PoC) diagnostics, and the growing disposable income in developing regions. These trends are being driven by increased funding for animal health from a variety of government & non-government organizations worldwide.
The players in the veterinary infectious disease diagnostics market are adopting many strategic initiatives, such as acquisitions, collaborations, mergers, and new product development, to increase their footprint. These initiatives enhance the company’s product portfolio and help them sustain in the market.
Based on technology, the veterinary infectious disease diagnostics industry is segmented into six segments: immunodiagnostics, clinical chemistry, hematology, urinalysis, molecular diagnostics, and other technologies. The immunodiagnostics segment dominated the industry in 2022. The rising demand for early disease detection & analysis and advancements in immunoassay formats are propelling the market.
According to infection type, the market is bifurcated into viral, bacterial, parasitic, and other infection types. Viral infections are the most common disease diagnosed in veterinary medicine, accounting for the largest share of the veterinary infectious disease diagnostics market in 2022. This can be attributed to the increasing prevalence of viral disease outbreaks such as West Nile virus, severe acute respiratory syndrome (SARS), avian influenza, and monkeypox. The growing need to prevent zoonotic infectious disease transfer is driving the market.
Based on region, the market is divided into five categories including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America dominated the market due to the region's easy availability of veterinary infectious disease diagnostic products, the rising pet adoption, and increasing animal healthcare spending. Another major factor contributing to market development is the increasing incidences of various infectious diseases in animals.
Some major market players operating in the veterinary infectious disease diagnostics market are Zoetis, Neogen Corporation, Randox Laboratories, Ltd., Thermo Fisher Scientific, Virbac, Idexx Laboratories, Inc., Virbac, DRG Instruments GmbH, Chembio Diagnostic Systems, Inc., Eurofins Technologies, and NTBIO Diagnostics Inc.